title: [Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid].
abstract: BACKGROUND
  Pemphigoid is a form of auto-immune bullous dermatosis characterised by the production of antibodies directed against components of hemidesmosomes in the basal membrane. The physiopathological process responsible for unmasking of these antigens is unknown. Pemphigoid is more common in elderly subjects and is most often seen in debilitated subjects. The prevalence of pemphigoid anti-pemphigoid antibodies (anti-PB) is not known in the elderly population presenting no dermatological signs evocative of the disease. We studied the prevalence of anti-PBAg2 antibodies in elderly subjects with no signs of pemphigoid as well as in the correlation between the presence of these antibodies and diagnosis of dementia.
  
  
  METHODS
  Elderly subjects (aged over 69 years) with no signs of pemphigoid were recruited consecutively in dermatology and geriatrics departments (138 subjects). Details of concomitant medication were recorded for all subjects and clinical examination was performed with calculation of MMS (Mini Mental Score). The subjects were then divided into two groups based on MMS score. The first group comprised subjects without dementia (MMS > 24) while the second comprised subjects with dementia. Serum anti-PBAg2 antibodies were determined by ELISA and indirect immunofluorescence with confirmation by Western blot. Antinuclear antibodies, used as a control for non-specific immune response, were assayed in all serum samples. The prevalence of these antibodies was compared between the two groups.
  
  
  RESULTS
  The two groups were comparable in terms of age, sex and presence of dermatological diseases (ulcers, bedsores, erysipelas). Each group comprised 69 subjects. The overall presence of anti-PBAg2 antibodies in subjects with no signs are suggestive of pemphigoid was 3.6%. Presence of anti-PBAg2 antibodies was associated with diagnosis of dementia (p=0.04; 0% and 7% in groups 1 and 2, respectively). No correlation was seen between the presence of anti-PBAg2 antibodies and concomitant medication or dermatological disease. The overall prevalence of antinuclear antibodies was 14.5% and the figure was similar between the two groups.
  
  
  CONCLUSIONS
  The presence of anti-PBAg2 could be associated with the diagnosis of dementia in elderly subjects.
authors.affiliation: Service de Gérontologie, Hôpital Charles Foix, Assistance Publique, Hôpitaux de Paris, Ivry-sur-Seine.
authors.forename: N
authors.initials: N
authors.lastname: Foureur
authors.forename: S
authors.initials: S
authors.lastname: Mignot
authors.forename: P
authors.initials: P
authors.lastname: Senet
authors.forename: P
authors.initials: P
authors.lastname: Verpillat
authors.forename: C
authors.initials: C
authors.lastname: Picard-Dahan
authors.forename: B
authors.initials: B
authors.lastname: Crickx
authors.forename: C
authors.initials: C
authors.lastname: Labarre
authors.forename: P
authors.initials: P
authors.lastname: Nicaise-Roland
authors.forename: V
authors.initials: V
authors.lastname: Descamps
mesh_terms: D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D003704:Dementia / Q000175:diagnosis / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D010391:Pemphigoid, Bullous / Q000276:immunology*; D011446:Prospective Studies
chemical_list: D001323:Autoantibodies